These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 7566619)

  • 1. Effect of calcium-channel blocker on tumour necrosis factor alpha (TNF alpha) production in cyclosporin-treated renal transplant recipients.
    Peces R; Urra JM
    Nephrol Dial Transplant; 1995; 10(6):871-3. PubMed ID: 7566619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of calcium channel blockers in diabetic renal transplant patients: preliminary observations on protection from sepsis.
    Weinrauch LA; D'Elia JA; Gleason RE; Shaffer D; Monaco AP
    Clin Nephrol; 1995 Sep; 44(3):185-92. PubMed ID: 8556835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of cyclosporin A and amlodipine: blood cyclosporin A levels, hypertension and kidney function.
    Schrama YC; Koomans HA
    J Hypertens Suppl; 1998 Sep; 16(4):S33-8. PubMed ID: 9817190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral health in renal transplant recipients administered cyclosporin A or tacrolimus.
    Spolidorio LC; Spolidorio DM; Massucato EM; Neppelenbroek KH; Campanha NH; Sanches MH
    Oral Dis; 2006 May; 12(3):309-14. PubMed ID: 16700742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of proinflammatory cytokine gene polymorphisms for development of insulin resistance after renal transplantation.
    Gençtoy G; Kahraman S; Arici M; Altun B; Erdem Y; Bakkaloğlu M; Yasavul U; Turgan C
    Transplant Proc; 2006 Mar; 38(2):521-8. PubMed ID: 16549165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of calcium channel antagonists on renal function in hypertensive heart transplant recipients.
    Bunke M; Ganzel B
    J Heart Lung Transplant; 1992; 11(6):1194-9. PubMed ID: 1457446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different profile of gene expression of cytokines in peripheral blood mononuclear cells of transplant recipients treated with m-TOR inhibitor and calcineurin inhibitor.
    Niemczyk M; Zegarska J; Pawłowska M; Wyzgał J; Ciszek M; Paczek L
    Transpl Immunol; 2009 Jan; 20(3):139-42. PubMed ID: 18834941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in renal function by felodipine during cyclosporine treatment in acute and short-term studies.
    Pedersen EB; Madsen JK; Sørensen SS; Zachariae H
    Kidney Int Suppl; 1996 Jun; 55():S94-6. PubMed ID: 8743522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of oral pentoxyfylline on the OKT3-induced cytokine-release syndrome among renal allograft recipients.
    Vasquez EM; Pollak R
    Clin Transplant; 1996 Jun; 10(3):294-7. PubMed ID: 8826669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine-A-based immunosuppression and renal functional reserve in organ-transplant patients.
    Kamar N; Allard J; Ader JL; Rostaing L
    Transplant Proc; 2004 Mar; 36(2 Suppl):248S-250S. PubMed ID: 15041347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OKT3 therapy increases cyclosporine blood levels.
    Vasquez EM; Pollak R
    Clin Transplant; 1997 Feb; 11(1):38-41. PubMed ID: 9067693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone resistance in kidney transplantation is in part induced by a down-regulation of mineralocorticoid receptor expression.
    Heering PJ; Kurschat C; Vo DT; Klein-Vehne N; Fehsel K; Ivens K
    Clin Transplant; 2004 Apr; 18(2):186-92. PubMed ID: 15016134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the effects of TNF in renal allograft recipients using recombinant human dimeric tumor necrosis factor receptors.
    Eason JD; Wee S; Kawai T; Hong HZ; Powelson JA; Widmer MB; Cosimi AB
    Transplantation; 1995 Jan; 59(2):300-5. PubMed ID: 7839455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive properties of calcium channel blockers.
    Chitwood KK; Heim-Duthoy KL
    Pharmacotherapy; 1993; 13(5):447-54. PubMed ID: 8247910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine-induced hypertension: evidence for maintained baroreflex circulatory control.
    Lucini D; Milani RV; Ventura HO; Mehra MR; Messerli FH; Murgo JP; Regenstein F; Copley B; Malliani A; Pagani M
    J Heart Lung Transplant; 1997 Jun; 16(6):615-20. PubMed ID: 9229291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients.
    Herman M; Weinstein T; Korzets A; Chagnac A; Ori Y; Zevin D; Malachi T; Gafter U
    J Lab Clin Med; 2001 Jan; 137(1):14-20. PubMed ID: 11150019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gingival enlargement in pediatric organ transplant recipients in relation to tacrolimus-based immunosuppressive regimens.
    Shiboski CH; Krishnan S; Besten PD; Golinveaux M; Kawada P; Tornabene A; Rosenthal P; Mathias R
    Pediatr Dent; 2009; 31(1):38-46. PubMed ID: 19320258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enalapril/amlodipine combination in cyclosporine-treated renal transplant recipients: a prospective randomized trial.
    Halimi JM; Giraudeau B; Buchler M; Al-Najjar A; Etienne I; Laouad I; Bruyère F; Lebranchu Y
    Clin Transplant; 2007; 21(2):277-84. PubMed ID: 17425758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour necrosis factor-alpha gene polymorphism: implications in kidney transplantation.
    Poli F; Boschiero L; Giannoni F; Tonini M; Scalamogna M; Ancona G; Sirchia G
    Cytokine; 2000 Dec; 12(12):1778-83. PubMed ID: 11097747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.